Vulpes Investment Management Pte Ltd
VC Fund
Singapore, Singapore
Vulpes Investment Management Pte Ltd is a VC fund in Singapore focused on Health Care and FinTech. Vulpes Investment Management is an alternative investment manager
- Total investments:
- 31
- Last investment:
- Lead investor:
- 26%
Last updated:
For AI agents: llms.txt
Industries Vulpes Investment Management Pte Ltd invests in
Stages Vulpes Investment Management Pte Ltd invests in
Countries Vulpes Investment Management Pte Ltd invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1M–$8M
- Series A
- $2M–$16M
- Post-IPO Equity
- $1.3M–$14M
Investment Focus
Industry
- Health Care 7 (23%)
- FinTech 5 (16%)
- Biotechnology 5 (16%)
- B2B 4 (13%)
- Internet 3 (10%)
Stage
- Seed 10 (32%)
- Series A 10 (32%)
- Post-IPO Equity 3 (10%)
- Convertible Note 3 (10%)
- Funding Round 2 (6%)
Country
- United Kingdom 7 (23%)
- Australia 5 (16%)
- Vietnam 4 (13%)
- Singapore 4 (13%)
- Philippines 3 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Field Pickering
Head of Venture Investing
|
Head of Venture Investing | Total investments: 9 | Find email | |
Jani Rautiainen
Venture Partner, Investment Committee Member
|
Venture Partner, Investment Committee Member | Total investments: 8 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oxford Biodynamics
|
Oxford BioDynamics Plc (AIM: OBD) ("Oxford BioDynamics") is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The Company’s award-winning, proprietary technology platform, EpiSwitch™, aims to accelerate the drug discovery and developmentprocess, improve the success rate of therap. | $12.3M / Post-IPO Equity / Aug 10, 2026 | |
RoseRx
|
Healthcare from home. Access online doctors and treatments anytime, anywhere. | Seed / Jun 07, 2025 | |
Scancell
|
Scancell is developing therapeutic vaccines for the treatment of cancer and infectious diseases based on its ImmunoBody® and Moditope™ technology platforms. Scancell’s first cancer vaccine SCIB1 is being developed for the treatment of melanoma and is in Phase 1/2 clinical trials. Preliminary evidence from Part 1 of the study showing that SCIB1produced an immune response which might be associated with clinical benefit in patients with malignant melanoma was released in December 2012. | $14.4M / Post-IPO Equity / Dec 06, 2024 | |
Oxford Endovascular
|
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal. | $10.2M / Series A / May 20, 2024 | |
Peddlr
|
Jumpstarting Philippine Micro and Small businesses to digital world. Peddlr is a free POS app for micro and small entrepreneurs in the Philippines and South East Asia that helps them earn more and better manage their businesses. | $4.3M / Seed / Feb 05, 2022 | |
MyRobin.id
|
MyRobin is an end-to-end talent hub that provides Indonesian businesses with pre-screened, quality workers on flexible contracts, both long and short term. MyRobin was launched in 2019 and is headquartered in Jakarta, Indonesia. | Seed / Jan 18, 2022 | |
FoodMap
|
FoodMap is a startup with the goal of connecting customers with ethical farmers and food suppliers directly. | $3M / Seed / Jan 05, 2022 | |
Tigerhall
|
Tigerhall is a change activation platform leveraged by Fortune 500 firms to activate Communications, Culture and Capability Building when undergoing major transformations such as mergers, acquisitions, divestitures, commercial transformations or significant reorganizations. | $7M / Series A / Dec 01, 2021 | |
CloudEats
|
CloudEats operates cloud kitchens and in-house restaurant brands. Its cloud kitchens are in non-retail and cost-efficient spaces, with operations and layouts specifically designed for food delivery. As of March 2020, the company has five cloud kitchens in the Philippines that house 70 in-house restaurant brands. All food brands are available on allfood delivery platforms including Grab Food, Foodpanda and Lalafood. | $5M / Series A / Oct 29, 2021 | |
Citics
|
Citics is to build a comprehensive real estate data platform in Vietnam by digitizing and centralizing data sources to help in real estate transactions, including real estate valuation, sales-purchase, lease, mortgage, among others. | $1.3M / Convertible Note / Oct 29, 2021 | |
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Vulpes Investment Management Pte Ltd invest in?
Vulpes Investment Management Pte Ltd invests primarily in Health Care, FinTech and Biotechnology startups, most often at Seed and Series A stage. Most of the 31 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Vulpes Investment Management Pte Ltd's check size?
Vulpes Investment Management Pte Ltd typically joins rounds of $1M–$8M at Seed, $2M–$16M at Series A and $1.3M–$14M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Vulpes Investment Management Pte Ltd participates in.
How do I contact Vulpes Investment Management Pte Ltd?
Public channels for Vulpes Investment Management Pte Ltd include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Vulpes Investment Management Pte Ltd?
The team at Vulpes Investment Management Pte Ltd includes Field Pickering (Head of Venture Investing) and Jani Rautiainen (Venture Partner, Investment Committee Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
